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Abstract
Background: To obtain non-relative measures of cell proteins, purified preparations of the same proteins are used as
standards in Western blots. We have previously quantified SV40 large T antigen expressed over a several fold range in
different cell lines and correlated the average number of molecules to average fluorescence obtained by cytometry and
determined cell cycle phase related expression by calculation from multi-parametric cytometry data. Using a modified
approach, we report quantification of endogenous cyclin B1 and generation of the cell cycle time related expression profile.
Methodology: Recombinant cyclin B1 was purified from a baculovirus lysate using an antibody affinity column and
concentrated. We created fixed cell preparations from nocodazole-treated (high cyclin B1) and serum starved (low cyclin B1)
PC3 cells that were either lyophilized (for preservation) or solubilized. The lysates and purified cyclin B1 were subjected to
Western blotting; the cell preparations were subjected to cytometry, and fluorescence was correlated to molecules. Three
untreated cell lines (K562, HeLa, and RKO) were prepared for cytometry without lyophilization and also prepared for
Western blotting. These were quantified by Western blotting and by cytometry using the standard cell preparations.
Results: The standard cell preparations had 1.5610
5 to 2.5610
6 molecules of cyclin B1 per cell on average (i.e., 16-fold
range). The average coefficient of variation was 24%. Fluorescence varied 12-fold. The relationship between molecules/cell
(Western blot) and immunofluorescence (cytometry) was linear (r
2=0.87). Average cyclin B1 levels for the three untreated
cell lines determined by Western blotting and cytometry agreed within a factor of 2. The non-linear rise in cyclin B1 in S
phase was quantified from correlated plots of cyclin B1 and DNA content. The peak levels achieved in G2 were similar
despite differences in lineage, growth conditions, and rates of increase through the cell cycle (range: 1.6–2.2610
6 molecules
per cell).
Conclusions: Net cyclin B1 expression begins in G1 in human somatic cells lines; increases non-linearly with variation in
rates of accumulation, but peaks at similar peak values in different cell lines growing under different conditions. This
suggests tight quantitative end point control.
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Introduction
To a very large extent, our knowledge of cellular regulation at the
molecular level rests on simple biochemical reactions correlated
with genetic interactions and ‘‘molecular genetic’’ interventions,
which are related to phenotype. In general this knowledge is
communicated with cartoons coupled with somewhat tortured text
to create a sense of understanding. Most of this knowledge is not
quantitative and the limited quantitative knowledge is based on
relative measurements. In recent years, momentum and enthusiasm
has grown for more integrated systems approaches to the study of
cell biology [1]. One cornerstone of these ‘‘Systems Biology’’ efforts
is mathematical modeling of the regulatory biochemical network of
the cell [2]. Our short term purpose for the work reported here is to
transformcytometrydataintonon-relative measurements. The long
term goal is to create a robust system of measurement on an
absolute scale that supplies the information that these systems efforts
require.
Quantification of specific cell protein contents is generally
measured and reported as relative values. There are exceptions
and these usually involve incorporating purified proteins as
standards in immunoblotting methods [e.g., 3], measuring
fluorescence of fluorescent proteins (FP) or of FP-fusion proteins
and external fluorescent protein standards on the same instrument
[4], and mass spectrometry [5]. Only the FP method provides
single cell resolution. We have previously coupled the immunoblot
approach with cell line standards, expressing different levels of
SV40 large T antigen (Tag) expressed over a several fold range, to
create a method whereby protein expression could be quantified in
absolute terms (molecules per cell) and correlated with any other
parameter by multi-parametric cytometry of the same cell lines
[6]. The method relied on correlating the average Tag-specific
fluorescence with the Optical Density (OD) of the Tag band on
western blots into which recombinant, purified SV40 Tag was also
incorporated. Because cytometry was used, this was also a single
cell method.
Here we report that we have extended this procedure to a
protein that oscillates during the cell cycle, cyclin B1. SV40 T
antigen is a long-lived protein expressed throughout the cell cycle
when expressed from its own promoter [7] or from recombinant
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at an expression rate that ranges less than two fold as a ratio of the
average G2 to average G1 cell. On the other hand, cyclin B1
ranges from an undetectable level in early G1 to 1000’s fold over
the earliest detectable levels with a very sharp, non-linear rise in
late S and G2 [10]. We faced several challenges for cyclin B1.
First, we did not have an obvious strategy to create cell lines that
expressed the protein over the many-fold range necessary to create
a standard curve. Second, the antibodies available to detect it had
significantly lower affinity than the Tag antibody; third, related to
the first, cyclin B1 was thought to be expressed at low levels
compared to a stable, promiscuously expressed protein like Tag.
Finally, we did not know whether the fluorescence averaging
method would work well when a large number of the cells were
not expressing the protein. In principle, this shouldn’t matter, but
coupled with the relatively low expression of cyclin B1, a
significant fraction of the fluorescence signal is background. The
last three problems are all related and depend on the quality of the
antibody.
Other investigators have measured cyclin B1 levels in HeLa
cells [4,11], mouse and Xenopus oocytes [12,13], and yeast [14].
The methods and results vary significantly. Here, we report results
for Hela, RKO, and K562. The methods used to quantify were
substantially different in each case and the direct comparisons of
Hela cells are not in agreement. The results of Xu et al. agree with
our results within two-fold. The results of Arooz et al. are different
by a large factor. It is not clear whether this is technical or
biological, although the difference in magnitude seems too great to
be biological, and examination of methodological points wherein
differences might occur on the order of two-fold doesn’t account
for the orders of magnitude difference in results.
Results and Discussion
Effect of Protein Concentration on Immunoblot
Detection of Purified Cyclin B1
Our previous experience with SV40 large T antigen (Tag)
showed that there were two important facets to Western blotting
that should be addressed for molecular quantification [6].
The quantity of protein loaded becomes important because the
purified recombinant proteins need to be applied as a dilution
series to create the standard. Protein content per sample affects the
distance a protein runs and the intensity of the band transferred to
the paper. Previously, we used NIH 3T3 cell lysates to equalize the
total protein levels in the recombinant dilutions of Tag. For cyclin
B1, we needed a non-replicating cell source or a replicating source
from a non-cross reacting species. Since either of these would
involve some difficulty, we investigated use of a single, purified
protein in lieu of cell lysates. We tried three different proteins. A
typical Western blot for trypsin inhibitor is shown in Figure 1A. In
this experiment, a constant amount of recombinant cyclin B1 was
mixed with variable amounts of trypsin inhibitor, which, at
21.5 kDa, migrates faster than cyclin B1 during electrophoresis.
The intensity of the cyclin B1 band changed in the expected
manner as a function of trypsin inhibitor concentration. The
results of 3 experiments were combined in Figure 1B and show
that 25–50 mg of trypsin inhibitor provide an optimal cyclin B1
signal. Beta-galactosidase, which migrates slower than cyclin B1,
showed the same pattern of increase in cyclin B1 intensity as
trypsin inhibitor. BSA, which migrates at about the level of cyclin
B1, interfered with cyclin B1 migration. In subsequent work,
trypsin inhibitor was added to the recombinant cyclin B1 and the
cells lysates to bring the total protein in each electrophoretic lane
to 50 mg/lane. We conclude that adding a purified protein is an
efficient way to optimize for protein concentration effect, however,
the type and amount appears empirical. For example, similar
experiments for Tag showed peak detection at 1.5 mg added b-
galactosidase.
The method of cell lysis is the second major variable. The
validity of quantitative Western blotting is dependent on
solubilization of all or most of the protein under study. This was
difficult for Tag because a significant fraction of Tag is tightly
bound to the nuclear matrix. To test whether cyclin B1 posed
similar problems, lysis buffers of different strengths were used to
extract cyclin B1 from PC3 and DU145 prostate cell lines. RIPA,
0.75% Triton X-100, and 1, 5, and 23% SDS did not show major
reproducible differences in cyclin B1 solubilization (Figure 2)
indicating that it is not tightly bound to insoluble cellular
structures. This was verified in additional experiments in which
cyclin B1 was not detectable by immunofluorescence cytometry or
Western blot of cells after Triton X-100 permeabilization and
washing (data not shown). SDS at 1% was used in subsequent
work.
Manipulation of Cyclin B1 Levels in Cell Lines
Our perception was that relative average levels of cyclin B1 do
not vary over a wide range between human cell lines or stimulated
peripheral blood lymphocytes. Therefore, to create cell prepara-
tions with a wider range, we manipulated the average expression
of cyclin B1 for cell populations by altering growth conditions.
Figure 1. Protein level affects epitope detection. (A) A fixed
amount of purified cyclin B1 (6.36 ng) was added to a serial dilution of
trypsin inhibitor (TI) and subjected to electrophoresis and Western
blotting. (B) Relative intensity of the cyclin B1 bands is presented
corresponding to trypsin inhibitor levels. Cyclin B1 intensity was
maximal at 25–50 mg trypsin inhibitor and decreased at lower and
higher protein levels. Densitometry readings from 3 experiments and 6
gels were combined by normalizing by linear regression on measure-
ments common to each paired series. The number of common points
ranged from 6 to 8. The combined set was then normalized to the 500
TI mean value, therefore the Y axis can be read as fold over this value.
doi:10.1371/journal.pone.0007064.g001
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early-mid G1 [15,16] and is thought to be essentially absent in G0,
therefore, growing cells to confluency or serum starvation should
decrease the average expression of cyclin B1. Conversely, growing
cells at a low density (3000–5000 cells/cm
2) enhances growth rate
and therefore increases the number of cells in G2 and M, during
which cyclin B1 levels peak. These extremes resulted in 3 and 4
fold ranges in average cyclin B1 expression for DU145 and PC3,
respectively (Figure 3A). To obtain populations with higher
average levels of cyclin B1, DU145 and PC3 cells were treated
with nocodazole to arrest cells in metaphase. Cyclin B1 is normally
at or near peak levels in metaphase. Additionally, when cells are
synchronized by any of several methods [17,18] or arrested with
nocodazole (this paper), cyclin B1 levels per cell increase to supra-
normal levels as a function of time. Compared to confluent
cultures, cyclin B1 intensity of treated DU145 cells increased 18
fold at 24 h (Figure 3B). Nocodazole treatment of PC3 cells
increased cyclin B1 levels 7 fold at 6h and 52 fold at 24 h
(Figure 3C).
Cyclin B1 Standard Cell Preparations
For standard cell preparations, nocodazole treated K562 cells
that normally express higher levels of cyclin B1, established the
high end of a standard set, and untreated 22Rv1 that normally
express lower levels defined the low end. For intermediate levels,
we used 2 batches of PC3 cells that were either confluent or had
been treated with nocodazole and mixed them in different
proportions. This provided fixed-cell preparations for cytometry
and lysates for Western blotting that evenly spanned a wide range
of average cyclin B1 levels.
For cytometry, we fixed large amounts of the standard samples
to be used for future experiments. To enhance long term storage of
these samples, we lyophilized the cytometry samples in multiple
vials and stored them at 280uC. Figure 4 shows that lysates of
lyophilized, MeOH-fixed, and freshly prepared PC3 cells do not
demonstrate significant differences in cyclin B1 levels. MeOH-
fixed cells, that are normally stored in 90% MeOH, lose immuno-
reactivity as a function of time are not quantitatively useful after
long periods (6 months – 1 year; unpublished data).
Cyclin B1 Quantification for Standards by Western blot
To determine the number of molecules of cyclin B1 in the
standard cell preparations, the preparations and purified,
recombinant cyclin B1 were electrophoresed on the same gel
and blotted on the same paper. The range of the purified cyclin B1
and the number of cells per lane were adjusted so that each cell
band was within the range of the purified standards. Each lane was
adjusted to equal protein content by adding trypsin inhibitor. A
representative Western blot of recombinant cyclin B1 with some
standard cell preparations is shown in Figure 5A. To quantify Tag,
we had adjusted the standard and the amount of cell lysate to give
Figure 3. Manipulation of cyclin B1 levels. Lysates were made
from known numbers of PC3 and DU145 cells that had either been
grown to confluence or harvested at very low density. Equal numbers of
cells were loaded in each lane and Western analysis of cyclin B1 was
performed. The increase in total cyclin B1 in subconfluent relative to
confluent cells was 4.4 fold for PC3 cells and 2.5 fold for DU145 cells (A).
Nocodazole (NDZ) treatment for the indicated hours produced a final
17.6 fold increase over confluent cells for DU145 cells (B) and a 52 fold
increase for PC3 cells (C).
doi:10.1371/journal.pone.0007064.g003
Figure 4. Comparison of MeOH fixed cells to MeOH fixed-
lyophilized cells. A culture of PC3 cells was trypsinized, washed, and
then divided into three equal parts. One part was solubilized for
electrophoresis, one part was fixed with methanol, and the third part
was fixed with methanol and then lyophilized. The methanol-fixed and
lyophilized cell preparations were washed then solubilized with 23%
SDS. The lanes were loaded with equal numbers of cells.
doi:10.1371/journal.pone.0007064.g004
Figure 2. Extraction of cyclin B1 in various lysis buffers. Equal
numbers of dissociated PC3 cells were solubilized in lysis buffer
containing RIPA, Triton X-100 or SDS (see Materials and Methods) and
analyzed for cyclin B1 by Western blot (A). Increasing the SDS level to
23% did not release more cyclin B1 (B). There was some variability
between lanes but, based on multiple gels, it was clear that cyclin B1
was readily extracted by all methods.
doi:10.1371/journal.pone.0007064.g002
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range of X-ray film. For cyclin B1 we used direct chemilumines-
cence detection with the FluorS MultiImager, which is linear over
3 orders of magnitude, so a wide range standard curve could be
generated. The relationship between band intensity and the
amount of cyclin B1 applied to each lane was determined by linear
regression. The band intensity, the number of cells per lane, the
regression slope and intercept, and the molecular weight of cyclin
B1 were then used to calculate the average number of cyclin B1
molecules per cell for each standard cell lysate (Table 1). From 3 to
5 determinations were made for each cell line. The average
coefficient of variation (CV) for all of the cell lines in the Western
Figure 5. Cytometry and quantitative Western blots of standards. (A) Left 4 lanes are recombinant cyclin B1 at two-fold dilutions.
Recombinant cyclin B1 and lysate concentrations were adjusted so that the band intensities for recombinant cyclin B1 spanned the range of those of
the lysates. Trypsin inhibitor was added to each sample to bring the total protein per lane to 50 mg. (B) Lyophilized standard cell preparations from
the same samples as used for Western blot were stained for cyclin B1 with GNS1-Alexa Fluor 647 (A647) and DNA (DAPI). Arrows indicate the mean
cyclin B1 fluorescence. Background fluorescence was subtracted and data were plotted as a hyperlog transformation which allows plotting of
negative and zero values on a linear lower section (210 to 10) and higher values (.10) logarithmically [22].
doi:10.1371/journal.pone.0007064.g005
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single lysate was used for each cell line. Therefore, this CV is an
assessment of technical variation.
Flow Cytometry of Standard Cells
Representative bivariate plots of the flow cytometric data
corresponding to the same cell populations used for the lysates are
shown in Figure 5B. Replicate samples were evaluated. G1 cells
are essentially negative for cyclin B1 during the period of APC/
C
Cdh1 activity (from anaphase – through some point in G1). These
cells were used for subtraction of non-specific binding of antibody
and autofluorescence (see Materials & Methods). The range of
average specific fluorescence values for the standard cell
preparations was ,12 fold (highest/lowest), while the range of
average cyclin B1 levels by Western blots was ,16 fold for the
same samples. In similar comparisons of Tag, cytometry produced
,4 fold range while Western blotting produced a 25 fold range
[6]. This equates to a 1.3 fold difference in range ratio here and an
,6 fold range ratio previously (Western range/cytometry range).
We interpret this to indicate that the cytometry here was improved
over the previous study. The Tag study differed with (1) a higher
affinity antibody, (2) secondary immunostaining, (3) fluorescein as
the fluorophore (compared to Alexa Fluor 647), and (4) X-ray film
(compared to CCD camera). Of these, it seems likely that use of
the brighter Alexa Fluor antibody that provides more photons in a
spectral region with less autofluorescence, and perhaps less non-
specific antibody staining (the antibody is used at a significantly
lower staining level and the fluor does not carry a net charge).
Analysis of the same standard cell preparations for cyclin B1 in this
study using primary or secondary immunostaining with fluorescein
isothiocyanate conjugated antibodies displayed only an approxi-
mately 2 fold range ratio, supporting this idea. The correlation
between cytometry in relative fluorescence units and Western
blotting (converted to molecules per cell) for the standard cell
preparations is shown in Figure 6).
Validation of Method with Test Cell Lines
To test the idea for using standard cells for cytometric quantifi-
cation of unknown samples, we prepared MeOH-fixed samples of
Hela, RKO, and K562 cells and quantified cyclin B1 by cytometry
using the lyophilized standard preparations. The test samples were
prepared and assayed in duplicate at the same time as the data for
Figure 6. Representative bivariate plots of cyclin B1 versus DNA
are shown in Figure 7A. We also prepared and assayed lysates of
these same cell preparations. Six Western blots were performed. A
representative blot is shown in Figure 7B. A plot of fluorescence
versus molecules per cell (determined by blotting) is shown in
Figure 7C (colored circles) plotted with the individual values for
the standard curve (white circles). A plot of molecules per cell
determined by cytometry and by Western blots is shown in
Figure 7D. Determination of molecules by cytometry and the
standard curve agreed with Western blotting for K562 (cytome-
try=1.2 X Western). However, for RKO, the cytometry/standard
curve method produced a mean that was 2.2 X that of the Western
blots. For HeLa cells, cytometry=0.4 X Western. These
differences are acceptable when compared to other efforts to
Table 1. Standard Curve.
Western Cytometer
Cell line Molecules/cell SE N Fluorescence SE N
K652 100% NDZ 2455442 420471 5 104 13.1 2
PC3 100% NDZ 1367914 237408 4 46 7.0 2
PC3 60% NDZ 717428 68438 4 33 5.4 2
PC3 30% NDZ 560111 64416 3 16 2.4 2
PC3 15% NDZ 361117 39964 3 11 1
22R 152219 8494 4 9 0.5 2
doi:10.1371/journal.pone.0007064.t001
Figure 6. Correspondence between cyclin B1 measured by
cytometry and by Western blotting. Average cyclin B1 levels were
calculated from luminescence measurements of imaged Western blots
then plotted versus mean fluorescence values (representative data
shown in Figure 5). (A) Means and the 95% confidence interval are
plotted. Cytometry was performed in duplicate. Western blots varied
from 3 to 6 replicates. Individual values are plotted in (B).
doi:10.1371/journal.pone.0007064.g006
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prediction interval for the standard curve (Figure 7C). However,
the error seem biased for the RKO and HeLa determinations.
Rather than being distributed evenly, all determinations except
one fall on one side or the other of the calculated correlation. If
this bias is real, we do not know the source, however, for HeLa
cells we have a speculative explanation. The HeLa sample was
very confluent with 92% of the cells in G1. This means that a
majority of the cells express levels of cyclin B1 that are below the
threshold of detection by cytometry (this is estimated to be below
3–5% of the maximum expression of cyclin B1 for HeLa cells
[19]). In this case, the higher sensitivity of Western blotting could
result in measuring the population average of cyclin B1, whereas
cytometry will register a large fraction of cells as zero (on average).
If this is substantiated, this approach is limited when populations
have high fractions of cells that express biomarker levels near the
threshold of detection by cytometry. Also, if substantiated, it may
be possible to derive a correction for this, at least for cyclin B1 and
similar epitopes, by determining the relationship between degree
of underestimate and cell density.
Cell Cycle-related Expression of Cyclin B1
Cyclin B1 increases non-linearly throughout the cell cycle [10].
This dynamic range is not obvious with Western blotting of
unsynchronized cells but is revealed by cytometry when addition
of DAPI is used to measure correlated DNA content and provide
measurements of the mean or median fluorescence for the G1, S,
G2+M phases of the cell cycle. Using the relationship described by
the data of Figure 6 to convert fluorescence to molecules, we
determined the expression of cyclin B1 in molecules per cell as a
function of progression through the cell cycle for the three test cell
line samples. These data were trimmed to include only the simple
2C cycle of G1 through metaphase. Figure 8A shows the arbitrary
regions used to determine the local cyclin B1 average and cell
frequency at that average. The cyclin B1 region specific
fluorescence was converted to molecules and plotted as a function
of cell frequency, which is proportional to time (Figure 8E–G).
Because cyclin B1 increases dramatically in the G2 phase of the
cell cycle, we anticipated that conversion to molecules as shown in
Figure 8 might be problematic if the region specific fluorescence
values were outside the range of the standard curve. However,
Figure 7. Test cell lines. Samples of HeLa, K562, and RKO were fixed with methanol then stained for cyclin B1 with GNS1-AlexaFluor 647 (A647) and
DNA (DAPI). Part of the sample was also lysed and subject to Western blot analysis in the same manner as the standard lysates described in Figure 5.
(A) cytometry data are displayed as in Figure 5. Arrows indicate the mean cyclin B1 related fluorescence. (B) Western blot prepared as in Figure 5. The
lanes for the test cell lines were not loaded with equal cell numbers; loading was adjusted to obtain bands with intensities within the range of the
cyclin B1 standards. Protein concentration was equalized with trypsin inhibitor. (C) co-plot of the standard curve and the test samples using the
measured values for cyclin B1 molecules obtained by Western analysis for the test samples. HeLa=red circles; K562=blue circles; RKO=green circles.
The 95% prediction band for the standard curve is plotted (dashed lines). (D) Molecules were determined by Western blotting (Y axis) and by
cytometry using the standard curve (X axis). The dashed line is a one-to-one correlation. Color coding is as in C.
doi:10.1371/journal.pone.0007064.g007
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endoreduplicated or binucleate cycling cells (4C 8C); mitotic cells after metaphase, and outliers. The purpose was to expose only the cells
distributed about the two dimensional center as a function of DNA content. These data represent the most common cycling cell in the population.
Arbitrary regions were set, moving through the data from early G1 through late G2+M( A–C). The mean cyclin B1 levels from each region are plotted
as a function of the cell frequency in the region (D–F). The frequency data were renormalized from the first non-zero cyclin B1 point and plotted to
compare the committed part of the cell cycle (cyclin B1 is detectable) for each cell line (G). In A-G, the X axis scale is 0–1, and the Y axis scale is 0–
4610
6.
doi:10.1371/journal.pone.0007064.g008
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blot measurements at the high end to supra normal levels, we did
not encounter this uncertainty.
To show the similarity of expression in greater detail, Figure 8G
shows the cell cycle related expression for all three samples starting
at the first significant value greater than 2% of max. We take this
to demark a position after the loss of Cdh1 activity and synthesis of
the mitotic B cyclins (we cannot detect cyclin A2 at this time in any
cell line that we have examined). This should also be within the
committed part of G1, although this is speculative. It may be useful
to note that despite the fact that these are three highly cultured
human tumor cell lines of different lineages (myeloid, colon,
cervical) and even though the HeLa cells were growing very slowly
as a population, the end point cyclin B1 levels are remarkably
close. This suggests tight quantitative regulation in an absolute
sense at the point at which the cyclin B1/Cdk1 complex becomes
active.
Other Approaches of Cyclin B1 Quantification
Data from other quantifications of cyclin B1 are listed in
Table 2. Each group used different methods, but ultimately relied
on Western blots for final quantification. There is a very wide
range of levels reported and some uncertainty about the exact size
of the cells within any one study, but if we either use the reported
concentrations or use cell size values that are reasonable, the
resulting cyclin B1 concentrations fall into groups with a difference
of 3 orders of magnitude between them. The yeast data [14] seem
to fall in an intermediate position, but these may be underesti-
mates. This group tagged all the proteins of interest with protein A
in order to quantify them against purified protein A and used
protein A antibody in Western blot detection. When this method
was checked with some untagged or myc-tagged proteins, the
protein A values were found to be lower in 3 out of 4 instances.
This suggests that the protein A tag may be reducing net
expression levels for some of the proteins.
All of these methods relied on Western blots for the final
quantification step, but used different variations. Some groups did
not control for total protein level. Some used ratios instead of
standard curves. But these differences seem minor compared to
the large gap in reported cyclin B1 concentrations. The two
groups with the lowest expression [11,13] used radioactivity to
quantify their standard, which was generated in a reticulocyte
lysate. We have noted endogenous B cyclin in reticulocyte lysates,
but both studies checked the values generated by reticulocyte
lysates against recombinant protein expressed in E. coli, so this
seems an unlikely source of error.
Despite careful reading of these papers, we do not see anything
technical that would account for the thousand-fold differences in
cyclin B1 values. For the study of Kobayashi et al., the variation
could be biology. If so, then Xenopus oocytes operate on much less
cyclin B1 compared to mammalian somatic cell lines. Since HeLa
cells were used in this study and that of Arooz et al. and Xu et al.
[4], the differences are particularly troubling. We would expect
that Xu et al. and our study would measure slightly higher levels
for G2+M cells since both studies employ cell based measurements
with enhanced ability to measure G2 and M, but this does not
explain the difference between these studies and that of Arooz et
al. We have preliminary data for an independent method similar
to that of Xu et al. We have used the fluorescence of a commercial
source of purified EGFP to quantify the expression of EGFP-cyclin
B1 expressing HeLa cells, and then used Western blots to quantify
endogenous cyclin B1 relative to EGFP-cyclin B1. The prelimi-
nary results support the higher values of endogenous cyclin B1 that
we have reported herein.
Materials and Methods
Purification of recombinant Cyclin B1
Baculovirus infected insect cells expressing recombinant human
cyclin B1 was a generous gift from Susan Wormsley (PharMingen,
San Diego, CA). To purify cyclin B1, 2.5610
8 cells were
suspended in 7 ml lysis buffer [50 mM Tris HCl, pH 7.0,
150 mM NaCl, 0.1% Na Azide, 2 mM phenylmethylsufonyl
fluoride (PMSF) and 10 ml/ml protease inhibitor cocktail (Sigma
P8340)]. An equal volume of lysis buffer with 2% Nonidet P-40
(NP-40) was added, and the lysate was stirred for 1 h at 4uC.
Insoluble material was removed by centrifugation at 15,000 g for
15 min at 4uC; 1 ml aliquots of supernatant were frozen in a dry
ice/EtOH bath and stored at 280uC.
Anti-cyclin B1 monoclonal antibody (GNS1, PharMingen) was
conjugated to Affi-Gel Hz (BioRad, Hercules, CA) as directed.
Four mg IgG was oxidized and coupled to 4 ml of Affi-Gel Hz.
Table 2. Comparison of Cyclin B1 Quantification.
Cells Phase/Stage Molecules/cell Diam. (u) Conc.(uM) Ref.
HeLa G2+M
a2610
6b 15 1.8 This study
HeLa Prometaphase 3610
6 15 2.9 [4]
HeLa G2
c4610
3 15 0.004 [11]
Mouse oocytes Incompetent 10
7d 55 0.2 [12]
Competent 10
8d 79 0.6
Xenopus oocytes stage VI 4610
8e 1280 0.0006 [13]
Yeast all (Clb2)
f 1610
3g 4.3 0.04 [14]
all (B cyclins) 4610
3g 4.3 0.15
aactual value=1.6610
6.
bUsed the value of Xu et al. [4]
cCalculated from the published values of pmole cyclin B1/g extract and 2610
3 cells/ug lysate.
dMeasured by Kanatsu-Shinohara et al. [12].
eEstimated from molecules and concentration given by Kobayashi et al. and diameter given by Chang et al. [23].
fcyclin type in parentheses.
gMeasured by Jorgensen et al. [24].
doi:10.1371/journal.pone.0007064.t002
Cyclin B1 Expression
PLoS ONE | www.plosone.org 8 September 2009 | Volume 4 | Issue 9 | e7064Absorbance at 280 nm was used to quantify coupling efficiency
(44%).
Lysate was added to the affinity column and the column was
washed using lysis buffer with 0.5% NP-40 (solution A) then with
solution A with 0.5 M NaCl until A280 returned to base line.
Cyclin B1 was eluted with 1M sodium propionate, 150 mM NaCl,
10% dioxane, and 0.5% NP40 at pH 5.0 (solution E). A shallow
gradient to 50% solution E followed by a steep gradient to 100%
solution E was used to collect fractions. Samples were frozen in dry
ice/ethanol and stored at 280uC. Fractions were monitored by
Western blotting. Cyclin B1 fractions were pooled and concen-
trated in 30K MW MSI Ultrafuge (Westboro, MA) centrifuge
filters. The concentrate was subjected to anion exchange
chromatography as follows. Pooled fractions were re-equilibrated
in solution A without NP-40 (EconoPac 10 DG, BioRad) then
concentrated in MSI Ultrafuge or Millipore (Bedford, MA)
Ultrafree-4 centrifuge filters and mixed with a Macro-Prep High
Q Support (BioRad) anion exchange resin in solution A. After
centrifugation the preparations were concentrated again to less
than 1 ml.
Cell Lines and Culture
PC3, DU145, RKO, HeLa, and 22Rv1 were grown in
Dulbecco’s modified Eagle medium (DMEM) with 5% FBS and
5% calf serum (Sigma, St. Louis, MO). K562 was grown in RPMI
1640 (Gibco, Grand Island, NY) with 10% FBS. All cultures were
maintained at 37uCi n5 %C O 2.
Cell line lysates
Adherent cells harvested with trypsin-EDTA or nonadherent
cells were counted with a Coulter Counter (Coulter, Hialeah, FL),
and then washed in PBS. Lysis buffer was added to give a final cell
concentration of between 5610
6/ml and 5610
7/ml, depending
on the cyclin B1 level in the cell line. Cells were lysed with SDS
lysis buffer (1% sodium dodecyl sulfate (SDS), 2% NP-40, 1% Na
deoxycholate, 137 mM NaCl, 20 mM Tris HCl, pH 7.5) and
DNA was sheared by syringing with a 26-gauge needle. SDS
concentration was varied to 5 or 23%. Other extraction buffers
used were RIPA (1% Na deoxycholate, 0.1% SDS, 1% Triton X-
100, 1 mM EDTA, 150 mM NaCl, 10 mM Tris HCl, pH 7.5),
TX-100 (0.75% Triton X-100, 0.5 M NaCl, 1 mM EDTA, 10%
glycerol, 20 mM Tris HCl, pH 8) and NP-40 (0.5% NP-40, 5 mM
MgCl2, 120 mM NaCl, 5 mM Tris HCl, pH 7.5). All lysis buffers
contained 2 mM PMSF and 10 ml/ml protease inhibitor cocktail
(Sigma). Extracts were stored at 220uC.
Protein content was measured by protein precipitation with
UPPA-1 and UPPA-2 (Geno Tech, St. Louis, MO) according to
the manufacturer’s directions; re-solubilization (0.1% SDS, 1%
deoxycholate, 0.5M NaOH), followed by the Lowry method [20].
BSA was used for the standard curve.
Quantitative Western Blotting
Western blotting was done as described previously [6]. The
primary antibody was 1.5 mg a-cyclin B1 clone GNS1 (PharMin-
gen) and the secondary was 5 ml alkaline phosphatase conjugated
goat-a-mouse IgG (Promega, Madison, WI) in 15 ml blocking
buffer. The substrate was CDP-star (Tropix, Bedford, MA). Blots
were imaged with a Flour-S MultiImager (BioRad) and images
analyzed with Quantity One software (BioRad).
Cell Fixation and Lyophilization
Single cell suspensions were fixed in 0.5% formaldehyde for
10 min at 37uC followed by 90% methanol at 220uC. Fixed cells
were lyophilized as individual samples in 1.5 ml centrifuge tubes
on a Labconco Freezone 12 Liter Freeze Dry System, model
77540 (Kansas City, MO) using histidine lyophilization buffer
(5 mM histidine, 0.1% Tween 20, 2 mM sucrose). Lyophilized
samples were stored in desiccators at 280uC. Samples were
rehydrated with distilled water equal to the amount of lyophili-
zation buffer used.
Immunofluorescence measurement
Samples were stained for cyclin B1 and DNA as previously
described [21]. Briefly, 5610
5 cells were incubated with 0.25 mg
GNS1, followed by washing, then incubated with 1.25 ug FITC-
conjugated goat anti-mouse IgG (1.25 mg). RNA was digested with
RNase and then propidium di-iodide was added at a final
concentration of 50 mg/ml. Cells were analyzed on a Coulter
EPICS XL- MCL Cytometer (Coulter Electronics, Miami, FL). In
some experiments, cells were stained with GNS1 conjugated to
Alexa Fluor 647 and phycoerythrin conjugated cyclin A2 antibody
(gift from Vince Shankey, Beckman Coulter, Miami, FL); DNA
was stained with DAPI, and cells were analyzed on a BD LSR I
Cytometer (BD Biosciences, San Jose, CA).
Data analysis
All data primary analysis was performed offline with WinList
6.0 (Verity Software House, Topsham, ME), and non-linear
regression was performed with GraphPad 5.0, GraphPad
Software, San Diego California USA).
Background Subtraction: To reduce background to near an
average of zero, we subtracted median fluorescence as a function
of cyclin B1 expression for G1 cells. Since cyclin B1 is not
expressed for much of G1, this provided a near perfect control for
background binding of the GNS1 antibody. This was accom-
plished in WinList (Verity Software House, Topsham, ME) using
compensation algorithms.
Calculation of molecules per cell
Optical densities (OD) from CCD exposure to Western blot
chemiluminescence from known numbers of cyclin B1-expressing
cells and from a serial dilution of purified recombinant cyclin B1
were used to determine the average molecules of cyclin B1 per cell.
Cytometry was used to obtain the average cyclin B1-related
fluorescence per cell for the same cell lines (duplicate cultures) used
in the Western blots. Linear regression was used to relate OD to
molecules and fluorescence to molecules for the standard and test
cell lines [6].
Calculation of cell cycle expression of cyclin B1
After background subtraction, gates on cyclin A2 versus light
scatter, DNA content versus light scatter, and cyclin B1 versus
DNA content were used to isolate only the 2C cycling component
from G1 through metaphase. Contiguous arbitrary regions were
set on cyclin B1 versus DNA content bivariate histograms from
early G1 through G2+M. Mean cyclin B1 levels per region were
plotted versus a cumulative function (1) of the cell frequency per
region.
ti~
fi=2 i~0 ðÞ
P j~i{1
j~0
fjzfi=2 iw0 ðÞ
8
> <
> :
where f= the frequency of cells within a region; i= the region
index beginning at 0 and progressively moving through the cell
cycle.
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